TSS
CPRX

Two Sigma Securities’s Catalyst Pharmaceutical CPRX Stock Holding History

Two Sigma Securities’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-12,277
Closed -$304K – 1833
2026
Q1 		$304K Buy
+12,277
New +$292K 0.04% 767
2024
Q2 		– Sell
-12,107
Closed -$193K – 3078
2024
Q1 		$193K Buy
+12,107
New +$182K ﹤0.01% 2356
2021
Q4 		– Sell
-25,664
Closed -$136K – 1611
2021
Q3 		$136K Buy
+25,664
New +$140K ﹤0.01% 1274
2020
Q4 		– Sell
-26,496
Closed -$79K – 1708
2020
Q3 		$79K Buy
+26,496
New +$104K ﹤0.01% 1195
2019
Q3 		– Sell
-10,336
Closed -$40K – 2103
2019
Q2 		$40K Sell
10,336
-14,309
-58% -$61.8K ﹤0.01% 1905
2019
Q1 		$126K Buy
+24,645
New +$72.4K ﹤0.01% 1542
2018
Q1 		– Sell
-26,658
Closed -$104K – 2695
2017
Q4 		$104K Buy
26,658
+15,178
+132% +$50.1K ﹤0.01% 1453
2017
Q3 		$29K Buy
+11,480
New +$31.5K ﹤0.01% 791
2017
Q2 		– Sell
-12,863
Closed -$25K – 905
2017
Q1 		$25K Buy
12,863
+1,260
+11% +$1.6K ﹤0.01% 838
2016
Q4 		$12K Buy
+11,603
New +$13.3K ﹤0.01% 668

Other funds holding CPRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Two Sigma Securities's CPRX Position: Q2 2026 in Review

Two Sigma Securities sold out of Catalyst Pharmaceutical (CPRX) in Q2 2026, closing a stake of 12,277 shares — an estimated $304K sold.

Two Sigma Securities first reported a position in CPRX in Q4 2016 and held it in 10 quarters. The position peaked at $304K in Q1 2026. 395 funds tracked by Wall St. Rank hold CPRX as of Q2 2026.

  • Two Sigma Securities reported no remaining Catalyst Pharmaceutical position as of Q2 2026 after selling out during the quarter.
  • Two Sigma Securities sold 12,277 Catalyst Pharmaceutical shares in Q2 2026, an estimated $304K.
  • Two Sigma Securities first reported a position in Catalyst Pharmaceutical in Q4 2016 and held it in 10 quarters.
  • Two Sigma Securities's Catalyst Pharmaceutical position peaked at $304K in Q1 2026.
  • 395 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q2 2026.

Based on Two Sigma Securities's 13F filing for Q2 2026, filed 14 Aug 2026.